MARSHALL WACE, LLP

Position in TMCI — Treace Medical Concepts, Inc.

CIK 1318757 LONDON, X0

Position in TMCI

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,287,796

+$4,932,787 QoQ

Shares Held

1,328,592

+401.5% QoQ

Ownership

2.04%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 116 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. TMCI ranks #21 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,287,796	1,328,592	+401.5%	Shares	Other	2026-08-13
2026-03-31	$355,009	264,933	+2153.2%	Shares	Other	2026-05-15
2025-09-30	$78,896	11,758	-91.3%	Shares	Other	2025-11-13
2025-06-30	$798,956	135,877	+256.2%	Shares	Other	2025-08-13
2025-03-31	$320,061	38,148	-57.1%	Shares	Other	2025-05-15
2024-12-31	$661,489	88,910	-79.2%	Shares	Other	2025-02-13
2024-09-30	$2,475,033	426,730	-7.8%	Shares	Other	2024-11-14
2024-06-30	$3,079,208	463,039	+65.9%	Shares	Other	2024-08-14
2024-03-31	$3,642,489	279,118	-48.1%	Shares	Other	2024-05-15
2023-12-31	$6,852,997	537,490	+1552.2%	Shares	Other	2024-02-14
2023-09-30	$426,481	32,531	-88.5%	Shares	Other	2023-11-14
2023-03-31	$7,126,376	282,905	+1093.3%	Shares	Other	2023-05-15
2022-09-30	$523,213	23,707	-30.1%	Shares	Other	2022-11-14
2021-12-31	$632,044	33,908	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.